Ornithine transcarbamylase deficiency with persistent abnormality in cerebral glutamate metabolism in adults

Radiology

Volumn 252, Issue 3, 2009, Pages 833-841

  Gropman, Andrea L ^a   Sailasuta, Napapon ^b   Harris, Kent C ^b   Abulseoud, Osama ^c   Ross, Brian D ^b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 13; GLUCOSE; GLUTAMIC ACID; ORNITHINE CARBAMOYLTRANSFERASE;

ADULT; ARTICLE; BRAIN METABOLISM; CARBON NUCLEAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME DEFICIENCY; FRONTAL LOBE; GLUCOSE BRAIN LEVEL; HUMAN; ISOTOPE LABELING; NEUROIMAGING; NEURORADIOLOGY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; BRAIN; CARBON ISOTOPES; CASE-CONTROL STUDIES; FEMALE; GLUCOSE; GLUTAMIC ACID; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY DISEASE;

EID: 70349286129     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2523081878     Document Type: Article

References (28)

1. Nagata N, Matsuda I, Matsuura T, et al. Retrospective survey of urea cycle disorders. II. Neurological outcome in forty-nine Japanese patients with urea cycle enzymopathies. Am J Med Genet 1991;40(4):477-481.
2. Applegarth DA, Toone JR, Lowry RB. Incidence of inborn errors of metabolism in British Columbia, 1969-1996. Pediatrics 2000; 105(1):e10.
3. Brusilow SW, Maestri NE. Urea cycle disorders: diagnosis, pathophysiology, and therapy. Adv Pediatr 1996;43:127-170.
4. Dionisi-Vici C, Rizzo C, Burlina AB, et al. Inborn errors of metabolism in the Italian pediatric population: a national retrospective survey. J Pediatr 2002;140(3):321-327. (Pubitemid 34289709)
5. Tuchman M, Jaleel N, Morizono H, Sheehy L, Lynch MG. Mutations and polymorphisms in the human ornithine transcarbamylase gene. Hum Mutat 2002;19(2):93-107. (Pubitemid 34121800)
6. Kang ES, Snodgrass PJ, Gerald PS. Ornithine transcarbamylase deficiency in the newborn infant. J Pediatr 1973;82(4):642-649.
7. Maestri NE, Clissold D, Brusilow SW. Neonatal onset ornithine transcarbamylase deficiency: a retrospective analysis. J Pediatr 1999;134(3):268-272. (Pubitemid 30417632)
8. McCullough BA, Yudkoff M, Batshaw ML, Wilson JM, Raper SE, Tuchman M. Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype. Am J Med Genet 2000;93(4):313-319. (Pubitemid 30497452)
9. Msall M, Batshaw ML, Suss R, Brusilow SW, Mellits ED. Neurologic outcome in children with inborn errors of urea synthesis: outcome of urea-cycle enzymopathies. N Engl J Med 1984;310(23):1500-1505.
10. Msall M, Monahan PS, Chapanis N, Batshaw ML. Cognitive development in children with inborn errors of urea synthesis. Acta Paediatr Jpn 1988;30(4):435-441. (Pubitemid 18229247)
11. Christodoulou J, Qureshi IA, McInnes RR, Clarke JT. Ornithine transcarbamylase deficiency presenting with strokelike episodes. J Pediatr 1993;122(3):423-425. (Pubitemid 23067226)
12. Maestri NE, Lord C, Glynn M, Bale A, Brusilow SW. The phenotype of ostensibly healthy women who are carriers for ornithine transcarbamylase deficiency. Medicine (Baltimore) 1998;77(6):389-397. (Pubitemid 28563641)
13. Mamourian AC, du Plessis A. Urea cycle defect: a case with MR and CT findings resembling infarct. Pediatr Radiol 1991;21(8): 594-595.
14. Pridmore CL, Clarke JT, Blaser S. Ornithine transcarbamylase deficiency in females: an often overlooked cause of treatable encephalopathy. J Child Neurol 1995;10(5):369-374.
15. Gyato K, Wray J, Huang ZJ, Yudkoff M, Batshaw ML. Metabolic and neuropsychological phenotype in women heterozygous for ornithine transcarbamylase deficiency. Ann Neurol 2004;55(1):80-86. (Pubitemid 38067364)
16. Gropman AL, Seltzer RR, Yudkoff M, Sawyer A, VanMeter J, Fricke ST. 1H MRS allows brain phenotype differentiation in sisters with late onset ornithine transcarbamylase deficiency (OTCD) and discordant clinical presentations. Mol Genet Metab 2008; 94(1):52-60.
17. Robinson MB, Hopkins K, Batshaw ML, McLaughlin BA, Heyes MP, Oster-Granite ML. Evidence of excitotoxicity in the brain of the ornithine carbamoyltransferase deficient sparse fur mouse. Brain Res Dev Brain Res 1995;90(1-2):35-44.
18. Bluml S, Moreno-Torres A, Ross BD. [1-13C]glucose MRS in chronic hepatic encephalopathy in man. Magn Reson Med 2001;45(6):981-993.
19. Sailasuta N, Robertson LW, Harris KC, Gropman AL, Allen PS, Ross BD. Clinical NOE 13C MRS for neuropsychiatric disorders of the frontal lobe. J Magn Reson 2008; 195(2):219-225.
20. Shic F, Ross B. Automated data processing of [1H-decoupled] 13C MR spectra acquired from human brain in vivo. J Magn Reson 2003;162(2):259-268.
21. Gropman AL, Fricke ST, Seltzer RR, et al. 1H MRS identifies symptomatic and asymptomatic subjects with partial ornithine transcarbamylase deficiency. Mol Genet Metab 2008;95(1-2):21-30.
22. Lin AP, Shic F, Enriquez C, Ross BD. Reduced glutamate neurotransmission in patients with Alzheimer's disease: an in vivo (13)C magnetic resonance spectroscopy study. MAGMA 2003;16(1):29-42.
23. Bluml S. In vivo quantitation of cerebral metabolite concentrations using natural abundance 13C MRS at 1.5 T. J Magn Reson 1999;136(2):219-225.
24. Magistretti PJ, Pellerin L. Cellular mechanisms of brain energy metabolism: relevance to functional brain imaging and to neurodegenerative disorders. Ann N Y Acad Sci 1996;777:380-387. (Pubitemid 26149218)
25. Mason GF, Petersen KF, de Graaf RA, Shulman GI, Rothman DL. Measurements of the anaplerotic rate in the human cerebral cortex using 13C magnetic resonance spectroscopy and [1-13C] and [2-13C] glucose. J Neurochem 2007;100(1):73-86.
26. Gruetter R, Seaquist ER, Kim S, Ugurbil K. Localized in vivo 13C-NMR of glutamate metabolism in the human brain: initial results at 4 tesla. Dev Neurosci 1998;20(4-5):380-388. (Pubitemid 28495533)
27. Moreno A, Ross BD, Bluml S. Direct determination of the N-acetyl-L-aspartate synthesis rate in the human brain by (13)C MRS and [1-(13)C]glucose infusion. J Neurochem 2001;77(1):347-350.
28. Kanamatsu T, Tsukada Y. Effects of ammonia on the anaplerotic pathway and amino acid metabolism in the brain: an ex vivo 13C NMR spectroscopic study of rats after administering [2-13C]] glucose with or without ammonium acetate. Brain Res 1999;841(1-2):11-19.